Medico Reach

MARCH 24, 2023

The American Cancer Society estimates 1,958,310 new cases of cancer in the United States in 2023. Hence, new oncology market trends will set in as doctors and pharmaceutical companies work towards individualized treatment decisions. billion in 2023 at a CAGR of 19.3%. billion by 2028. billion in 2022 to $12.8 billion by 2030.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Medico Reach

MARCH 24, 2023

The American Cancer Society estimates 1,958,310 new cases of cancer in the United States in 2023. Hence, new oncology market trends will set in as doctors and pharmaceutical companies work towards individualized treatment decisions. billion in 2023 at a CAGR of 19.3%. billion by 2028. billion in 2022 to $12.8 billion by 2030.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Legacy MEDSearch

JUNE 22, 2023

Food and Drug Administration (FDA) clearance to use the Topcon NW400 retinal camera with its EyeArt AI system to automatically detect diabetic retinopathy (DR), adding to the already-cleared usage with Canon CR-2 AF and Canon CR-2 Plus AF cameras. ” This latest FDA clearance for the EyeArt v2.2.0 sensitivity and 91.1%

FDA 52

FDA Food and Drug Administration Recruitment Marketing 52

pharmaphorum

AUGUST 1, 2022

Sarepta is pressing forward with a bold plan to file with the FDA for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD) in the next few months, with a view to making it available in sometime around the middle of 2023.

FDA 93

FDA Safety Patients Doctors 93

Pharmaceutical Technology

JANUARY 6, 2023

Last year, Novartis began with a win in January, as the US Court of Appeals affirmed the validity of Gilenya’s patent, allowing the company to sue a competitor generics company for filing for FDA approval for its Gilenya generic. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

MARCH 17, 2023

But while appealing, the prospects of developing a merged approach that combines both digital and pharmacological therapeutics remain challenging. In the US, a group of lawmakers recently reintroduced the “Access to Prescription Digital Therapeutics Act of 2023” in the US Senate.

Prescription 111

Prescription Pharmacology Pharma Medical 111

Evolve Your Success

APRIL 11, 2023

We have launched into the US marketplace and got the product design through FDA. In the second quarter of 2023, we said, “COVID moved past the time where it’s critical. That’s an individual doctor change. You need to sell to those individual doctors. Online is the new prospecting tool.

Sales 52

Sales Medical Medical sales Media 52